newsfilter
← Latest News
GlobeNewswire·

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024

Company advancing pipeline of potential best-in-class orexin receptor 2 (OX2R) agonists Initiated Phase 1 clinical study with ORX750 being developed for sleep-wake disorders; Safety and efficacy data in acutely